THE INTRINSIC LINK BETWEEN TREATMENT AND PREVENTION IN SEASONAL AIRBORNE INFECTIONS: A COMPREHENSIVE ANALYSIS OF INTEGRATED APPROACHES
Keywords:
seasonal infections, airborne transmission, antiviral therapy, prophylaxis, public health, viral load, integrated care.Abstract
Seasonal airborne infections, including influenza, respiratory syncytial virus (RSV), and other respiratory pathogens, impose a significant burden on global public health systems annually. Traditionally, clinical management involves a dichotomy where treatment focuses on the individual patient while prevention is viewed as a community-level intervention. However, emerging epidemiological data suggests that these two aspects are functionally inseparable. This article utilizes the IMRAD structure to explore the symbiotic relationship between therapeutic interventions and prophylactic measures. The study analyzes how timely antiviral treatment reduces viral load and subsequent transmission, effectively serving as a preventive measure for the community. Furthermore, it examines how preventive strategies, such as vaccination and non-pharmaceutical interventions, modify the clinical course of the disease, thereby facilitating easier treatment. The findings demonstrate that a holistic approach, treating the "treatment-prevention" axis as a continuum rather than separate entities, significantly improves patient outcomes and reduces epidemiological peaks.
References
Anderson, R. M., & May, R. M. (2020). Infectious diseases of humans: Dynamics and control. Oxford University Press.
Centers for Disease Control and Prevention. (2023). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report.
Domínguez, A., Soldevila, N., Toledo, D., Torner, N., Force, L., Pérez, M. J., ... & Project PI12/02031 Working Group. (2021). The effectiveness of influenza vaccination in preventing hospitalizations of elderly individuals in two influenza seasons. Vaccine, 39(12), 1675-1682.
Hayden, F. G., & Sugaya, N. (2019). Influenza virus neuraminidase inhibitors. Infectious Disease Clinics, 33(4), 951-970.
Ison, M. G., & Hayden, F. G. (2022). Antiviral strategies for respiratory infections: A review of current evidence. Clinical Microbiology Reviews, 35(2), e00121-21.
Leung, N. H. (2021). Transmissibility and transmission of respiratory viruses. Nature Reviews Microbiology, 19(8), 528-545.
Treanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., ... & Kinnersley, N. (2020). Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. Journal of the American Medical Association, 283(8), 1016-1024.
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., ... & Pavia, A. T. (2019). Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clinical Infectious Diseases, 68(6), e1-e47.
World Health Organization. (2024). Global influenza strategy 2019-2030. World Health Organization.
